Rebecca Attwood

Page 3

Clinician scientists in Southampton have shown a rare form of cancer can be treated with a drug that’s already available on the NHS. Hairy Cell Leukaemia (HCL) is a chronic leukaemia and gets its name from the tiny, hair-like projections on the cell’s surface. Current treatment is usually chemotherapy which has many side effects and does not eradicate the disease completely. Continue reading →

Scientists in Southampton have shown a rare form of cancer can be treated with a drug that’s already available on the NHS. Hairy Cell Leukaemia (HCL) is chronic leukaemia and gets its name from the have tiny, hair like outgrowths on the cells’ surface. Current treatment is usually chemotherapy which has many side effects and does not eradicate the disease completely. Continue reading →

Scientists and researchers from the Centre for Cancer Immunology have been presenting their work at several conferences across the globe over the past few weeks. Professors Peter Johnson and Sean Lim attended the Lugano International Conference on Malignant Lymphoma. Professor Johnson delivered the prestigious John Ultmann Memorial Lecture detailing 25 years of Antibodies in Lymphoma. Continue reading →

Scientists and researchers from the Centre for Cancer Immunology have been presenting their work at several conferences across the globe over the past few weeks. Professors Peter Johnson and Sean Lim attended the Lugano International Conference on Malignant Lymphoma. Professor Johnson delivered the prestigious John Ultmann Memorial Lecture detailing 25 years of Antibodies in Lymphoma. Continue reading →

Scientists and researchers from the Centre for Cancer Immunology have been presenting their work at several conferences across the globe over the past few weeks. Professors Peter Johnson and Sean Lim attended the Lugano International Conference on Malignant Lymphoma. Professor Johnson delivered the prestigious John Ultmann Memorial Lecture detailing 25 years of Antibodies in Lymphoma. Continue reading →

A professor, based at the Centre for Cancer Immunology, has been appointed to a national role aiming to improve and expand cancer services in the UK. Peter Johnson, Professor of Oncology, has been named as the UK Government’s new Cancer Mission Chair. The Cancer Healthcare Mission aims to drive progress and innovation in responding to some of the biggest healthcare issues of our times. Continue reading →

Scientists at the Centre for Cancer Immunology are to begin a new study to better understand why certain natural killer T cells are more effective against cancer than others. In pre-clinical studies, Invariant Natural Killer T (iNKT) cells have been shown to fight cancer as well as stimulate an anti-cancer reaction in the body. However, translation into human cancer patient trials has been less successful. Continue reading →

Scientists at the Centre for Cancer Immunology are to begin a new study to better understand why certain natural killer T cells are more effective against cancer than others. In pre-clinical studies, Invariant Natural Killer T (iNKT) cells have been shown to fight cancer as well as stimulate an anti-cancer reaction in the body. However, translation into human cancer patient trials has been less successful. Continue reading →

The Southampton Clinical Trials Unit (SCTU) based at the Centre for Cancer Immunology has been given a multi-million-pound boost by Cancer Research UK. Ahead of International Clinical Trials Day (May 20th), Cancer Research UK has announced it is to invest £5.5m at the SCTU over the next five years, to run world-leading trials which test new cancer treatments and help find ways to diagnose the disease at an earlier stage. Continue reading →